Insider buying
~$101K12K sh @ $8.07
Traded May 14, 2025 · filed 1 day later
An Organon director paid $101K out of pocket for Organon shares. 5 other people at Organon bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
OGN · NYSE · Pharmaceuticals
Organon & Co. (OGN) · oqro.io/stocks/OGN · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$13.89−0.02 (−0.14%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
18 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider buying
Traded May 14, 2025 · filed 1 day later
An Organon director paid $101K out of pocket for Organon shares. 5 other people at Organon bought some too, in the same month.
Insider buying
Traded May 6, 2025 · filed 1 day later
Organon's Gen. Counsel & Corp. Secy. paid $74K out of pocket for Organon shares. 5 other people at Organon bought some too, in the same month. Shares held went up 18% with this purchase.
Insider buying
Traded May 7, 2025 · filed the same day
Organon's Chief Human Resources Officer paid $48K out of pocket for Organon shares. 5 other people at Organon bought some too, in the same month. Shares held went up 10% with this purchase.
Insider buying
Traded May 6, 2025 · filed 1 day later
Organon's Executive VP, Corp. Dev. paid $29K out of pocket for Organon shares. 5 other people at Organon bought some too, in the same month. Shares held went up 8% with this purchase.
Insider buying
Traded May 5, 2025 · filed 1 day later
The CEO of Organon paid $299K out of pocket for Organon shares. 5 other people at Organon bought some too, in the same month. Shares held went up 14% with this purchase.
Insider buying
Traded May 5, 2025 · filed 1 day later
The CFO of Organon paid $101K out of pocket for Organon shares. 5 other people at Organon bought some too, in the same month. Shares held went up 9% with this purchase.
0 open-market purchases and 0 open-market sales by insiders of OGN between Jul 6, 2025 and today, placed against the company's last 4 earnings releases. The latest on file was filed Apr 30, 2026. The data provider lists the next release for Feb 10, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Apr 30, 2026 | None | None | None |
| Feb 12, 2026 | None | None | None |
| Nov 10, 2025 | None | None | None |
| Aug 5, 2025 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies